HLA class II favors clearance of HCV infection and progression of the chronic liver damage

Journal of Hepatology

Volumn 30, Issue 6, 1999, Pages 984-989

  Mangia, Alessandra ^a   Gentile, Raffaela ^a   Cascavilla, Isabella ^a   Margaglione, Maurizio ^a   Villani, Maria Rosaria ^a   Stella, Francesco ^b   Modola, Giovanni ^a   Agostiano, Valeria ^b   Gaudiano, Carlo ^b   Andriulli, Angelo ^a  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b Hospital of Trani   (Italy)

Author keywords

Genetic predisposition; HCV; HLA; Immunogenetics; Viral hepatitis

Indexed keywords

HLA ANTIGEN CLASS 2; INTERFERON;

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; HAPLOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HEREDITY; HUMAN; LIVER CIRRHOSIS; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VIREMIA; VIRUS CARRIER;

EID: 0033057855     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80250-5     Document Type: Article

References (24)

1. Peano G, Menardi G, Ponzetto A, Fenoglio LM. A genetic factor influencing the outcome of hepatitis C virus infection? Arch Intern Med. 154:1994;2733-2736.
2. Blair CS, Haydon GH, McColl M, Yap PL, Hayes PC. HLA status and severity and progression of chronic hepatitis C virus infection. [abstract] Hepatology. 24:1996;149A.
3. Czaja AJ, Carpenter H, Santrach PJ, Moore SB. DR human leukocyte antigens and disease severity in chronic hepatitis C. J Hepatol. 24:1996;666-673.
4. Zavaglia C, Bortolon C, Ferroli G, Rho A, Mondazzi L, Bottelli R, et al. HLA typing in chronic type B, D, and C hepatitis. J Hepatol. 24:1996;658-665.
5. Höhler T, Gerken G, Notghi A, Knolle P, Lubjuhn R, Taheri H, et al. MHC class II genes influence the susceptibility to chronic active hepatitis C. J Hepatol. 27:1997;259-264.
6. Thursz MR, Yallop R, Mantafounis D, Trepo C, Thomas H, for the HENCORE Group . MHC class II and the outcome of HCV infection. [abstract] J Hepatol. 28:(suppl.1):1998;95.
7. Tibbs C, Donaldon P, Underhill J, Thomson L, Manabe K, Williams R. Evidence that the HLA DQA1*03 allele confers protection from chronic-HCV infection in Northen European Caucasoids. Hepatol. 24:1996;1342-1345.
8. Zavaglia C, Martinetti M, Silini E, Bottelli R, Daielli C, Asti M, et al. Association between HLA class II alleles and protection from or susceptibility to chronic hepatitis C. J Hepatol. 28:1998;1-7.
9. Kuzushita N, Hayashi N, Moribe T, Katayama K, Kanto T, Nakatani S, et al. Influence of HLA haplotypes on the clinical courses of individuals infected with hepatitis C virus. Hepatology. 27:(1):1998;240-244.
10. Vitte RL, Fortier C, Richardet JP, Grimbert S, Trinchet JC, Beaugrand M, et al. HLA antigens in patients with chronic hepatitis C. Tissue Antigens. 45:1995;356-361.
11. Chen DF, Endres W, Kliem V, Tillmann HL, Brukhorst R, Koch KM, et al. No significant influence of HLA determinants on susceptibility to hepatitis C virus infection in Caucasian patients with end- stage renal disease. Liver. 16:1996;384-389.
12. Menardi G, Peano GM, Rovere A, Besso L, Fenoglio S, Ghezzi PM. HLA A-B-C and DR typing in HCV Ab positive and negative uremic patients undergoing maintenance haemodialysis: preliminary report. Giorn Ital Nefr. 9:1992;197-201.
13. Congia M, Clemente MG, Dessi C, Cucca F, Mazzoleni AP, Frau F, et al. HLA class II genes in chronic hepatitis C virus infection and associated immunological disorders. Hepatology. 24:1996;1338-1341.
14. Alric L, Fort M, Izopet J, Vinel JP, Charlet JP, Selves J, et al. Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection. Gastroenterology. 113:1997;1675-1681.
15. Cramp ME, Rossol S, Carucci P, Williams R, Naumov NV, Donaldson PT. The influence of the HLA class II allele DQB1*0301 on HCV specific T helper cell response. [abstract] J Hepatol. 28:(suppl.1):1998;94.
16. Shindo M, Di Bisceglie AM, Cheung L. Decrease of serum hepatitis C viral RNA during alpha interferon therapy for chronic hepatitis C. Ann Intern Med. 115:1991;700-704.
17. Shakil AO, Conry-Cantilena C, Alter HJ, Hayashi P, Kleiner DE, Tedeski V, et al. the Hepatitis C Study Group . Volunteer blood donors with antibody to hepatitis C virus: clinical, biochemical, virologic and histologic features. Ann Intern Med. 123:1995;330-337.
18. Shindo M, Arai K, Sokawa Y, Okuno T. The virological and histological states of anti-hepatitis C virus positive subjects with normal liver biochemical values. Hepatology. 22:1995;418-425.
19. Prieto M, Olaso V, Verdu C, Cordoba J, Gisbert C, Rayon M, et al. Does the healthy hepatitis C virus carrier state really exist? An analysis using polymerase chain reaction. Hepatology. 22:1995;413-417.
20. Piton A, Poynard T, Imbert-Bismut F, Khalil L, Delattre J, Pelisser E, et al. for the MULTIVIRC Group . Factors associated with serum alanine transaminase activity in healthy subjects: consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C. Hepatology. 27:1998;1213-1219.
21. Puoti C, Magrini A, Stati T, Rigato P, Montagnese F, Rossi P, et al. Clinical, histological, and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levels. Hepatology. 26:1997;1393-1398.
22. Stanley AJ, Haydon GH, Piris J, Jarvis LM, Hayes PC. Assessment of liver function in patients with hepatitis C and normal transaminase levels. Eur J Gastroenterol Hepatol. 8:1996;869-872.
23. Tillman HL, Chen DF, Boker K, Trautwein C, Kubicka S, Endres W, et al. HLA-phenotypes in patients suffering from HCV induced end-stage liver cirrhosis with and without hepatocellular carcinoma requiring transplantation. [abstract] Hepatology. 24:1996;392A.
24. Thursz MR, Kwiatkowski D, Allsopp CE, Torok ME, Greenwood BM, Thomas HC, et al. Heterozygote advantage at the MHC class II loci in the outcome of HBV infection. Nat Genet. 17:1997;10-11.